Skip to main content
. Author manuscript; available in PMC: 2011 Jun 15.
Published in final edited form as: Cancer. 2010 Jun 15;116(12):2941–2953. doi: 10.1002/cncr.25030

Figure 3. Sensitivity analysis on select variables for gastric dysplasia.

Figure 3

Graph depicts univariate sensitivity analyses for EMR with surveillance every 1 year. Values in parentheses indicate upper and lower bounds for each variable. The vertical dashed line indicates the incremental cost-effectiveness ratio for the base case. Bold line represents the commonly used $100,000 per QALY cost-effectiveness threshold.